Consolidated Statements of Operations And Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues	$ 140,177	$ 98,159
Research and development expenses (Note 10)	(497,121)	(489,210)
General and administrative expenses (Note 11)	(682,859)	(523,663)
Share base compensation expenses (Notes 8, 9)	(3,485,830)
Operating loss	(4,525,633)	(914,714)
Financing income (expenses), net	(71,180)	41,921
Comprehensive loss	$ (4,596,813)	$ (872,793)
Loss per common stock (basic and diluted)	$ (0.00)	$ (0.00)